Both in Pharmaceuticals
Harmony Biosciences Holdings vs Viridian Therapeutics
Over the past year HRMY returned +42.1% and VRDN returned −7.5%; their daily moves had a correlation of 0.16.
HRMY +42.1% VRDN −7.5%Growth of $1, one year, split-adjusted
| Metric | HRMY | VRDN |
|---|---|---|
| Price | $39.29 | $20.00 |
| Market cap | $2.29B | $2.27B |
| Today | −1.80% | −2.80% |
| 1 month | +0.2% | −13.4% |
| 6 months | +46.1% | +7.9% |
| Year to date | +5.0% | −35.7% |
| 1 year | +42.8% | −1.0% |
| Revenue growth (YoY) | +30.3% | +278.7% |
| Gross margin | 75.8% | 100.0% |
| Net margin | 28.9% | −39726.8% |
| P/E (TTM) | 12.6× | — |
| Price / sales | 2.4× | 31.8× |
| Net cash | $513.8M | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 41.5% | 45.8% |
| Short % of float | 10.1% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).